Rational Vaccines Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2.8M

  • Investors
  • 13

Rational Vaccines General Information

Description

Developer of a live-attenuated viral immunotherapeutic and prophylactic vaccine intended to combat all diseases resulting from herpes simplex virus. The company developed rationally engineered, live-attenuated viral immunotherapeutic and prophylactic vaccine candidates to reduce the spread of the virus and better control the symptoms caused by the reactivation of their wild-type herpetic infection, enabling physicians to help improve the lives of patients afflicted with herpes-related infections.

Contact Information

Website
www.rationalvaccines.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8 Cabot Road
  • Suite 3800
  • Woburn, MA 01801
  • United States
+1 (781)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 8 Cabot Road
  • Suite 3800
  • Woburn, MA 01801
  • United States
+1 (781)

Rational Vaccines Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rational Vaccines Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Grant 13-Oct-2023 $2.8M Completed Startup
8. Later Stage VC (Series B) 01-Jun-2023 Completed Pre-Clinical Trials
7. Later Stage VC 28-Jun-2022 Completed Pre-Clinical Trials
6. Later Stage VC (Series A) 01-Mar-2022 Completed Pre-Clinical Trials
5. Later Stage VC 30-Sep-2021 Completed Pre-Clinical Trials
4. Early Stage VC (Series A3) 15-Feb-2019 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) Completed Pre-Clinical Trials
2. Seed Round 05-Sep-2017 $8.25M $8.99M Completed Pre-Clinical Trials
1. Seed Round 30-Sep-2015 $740K $740K Completed Startup
To view Rational Vaccines’s complete valuation and funding history, request access »

Rational Vaccines Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A3
Series A2
Series A1
Series A
Seed-2
Seed-1 4,140,214 $0.000010 $0.09 $1.09 $1.09 1x $1.09 6.74%
Seed 2,322,492 $0.000010 $0.02 $0.3 $0.3 1x $0.3 3.78%
To view Rational Vaccines’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Rational Vaccines Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 5

    Pending

  • Expiring in next 12 mo

Rational Vaccines Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4366769-A1 Vaccines for intracellular pathogens and methods of production Pending 07-Jul-2021
US-20240174986-A1 Mutant herpesvirus and vaccine compositions Pending 29-Mar-2021
US-20230358746-A1 Methods and kits for determining serostatus of sars-cov-2 Inactive 06-Oct-2020
EP-4225953-A1 Methods and kits for determining serostatus of sars-cov-2 Pending 06-Oct-2020
CA-3197856-A1 Methods and kits for determining serostatus of sars-cov-2 Pending 06-Oct-2020 G01N33/56983
To view Rational Vaccines’s complete patent history, request access »

Rational Vaccines Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rational Vaccines Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government Minority
Gaingels Venture Capital Minority
AAF Management Venture Capital Minority
Flight Ventures Venture Capital Minority
10X Capital Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Rational Vaccines FAQs

  • When was Rational Vaccines founded?

    Rational Vaccines was founded in 2015.

  • Where is Rational Vaccines headquartered?

    Rational Vaccines is headquartered in Woburn, MA.

  • What is the size of Rational Vaccines?

    Rational Vaccines has 17 total employees.

  • What industry is Rational Vaccines in?

    Rational Vaccines’s primary industry is Biotechnology.

  • Is Rational Vaccines a private or public company?

    Rational Vaccines is a Private company.

  • What is Rational Vaccines’s current revenue?

    The current revenue for Rational Vaccines is .

  • How much funding has Rational Vaccines raised over time?

    Rational Vaccines has raised $75.9M.

  • Who are Rational Vaccines’s investors?

    National Institutes of Health, Gaingels, AAF Management, Flight Ventures, and 10X Capital are 5 of 13 investors who have invested in Rational Vaccines.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »